Status:
COMPLETED
Proton Therapy for Unresectable Cancer (CA) of Pancreas
Lead Sponsor:
University of Florida
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation and chemotherapy has on you and your pancreatic cancer.
Detailed Description
Chemotherapy:Capecitabine on radiation days Proton radiation over 7 weeks Consolidation Chemotherapy:Gemcitabine
Eligibility Criteria
Inclusion
- Pathologically confirmed adenocarcinoma of the pancreas.
- Patients must be medically inoperable or have unresectable disease
Exclusion
- Evidence of distant metastasis; evidence of metastatic disease in the major viscera (organs), peritoneal seeding and/or ascites.
- Previous irradiation to the abdomen that would compromise the ability to deliver the prescribed treatment.
- Prior surgical resection.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2017
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00685763
Start Date
March 1 2008
End Date
June 29 2017
Last Update
August 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States, 32206